Simplex Trading
ALXO icon

Simplex Trading’s ALX Oncology ALXO Stock Holding History

Simplex Trading’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,553
Closed -$6.77K – 8966
2025
Q4 		$4.01K Buy
+3,553
New +$5.38K ﹤0.01% 7543
2025
Q2 		– Sell
-391
Closed -$197 – 8536
2025
Q1 		$0 Sell
391
-14,176
-97% -$17K ﹤0.01% 8423
2024
Q4 		$24K Sell
14,567
-2,579
-15% -$3.96K ﹤0.01% 6520
2024
Q3 		$31K Buy
+17,146
New +$63.7K ﹤0.01% 6313
2024
Q2 		– Sell
-3,514
Closed -$43.2K – 8686
2024
Q1 		$39K Sell
3,514
-4,366
-55% -$61.3K ﹤0.01% 6486
2023
Q4 		$117K Sell
7,880
-1,580
-17% -$15K ﹤0.01% 5224
2023
Q3 		$45K Sell
9,460
-71
-0.7% -$385 ﹤0.01% 5898
2023
Q2 		$71K Buy
+9,531
New +$62.4K ﹤0.01% 5465
2023
Q1 		– Sell
-57
Closed -$432 – 8917
2022
Q4 		$0 Buy
+57
New +$640 ﹤0.01% 9110
2021
Q2 		– Sell
-94
Closed -$5.63K – 9954
2021
Q1 		$6K Buy
+94
New +$7.4K ﹤0.01% 8121

Other funds holding ALXO

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Simplex Trading's ALXO Position: Q1 2026 in Review

Simplex Trading sold out of ALX Oncology (ALXO) in Q1 2026, closing a stake of 3,553 shares — an estimated $6.77K sold.

Simplex Trading first reported a position in ALXO in Q1 2021 and held it in 10 quarters. The position peaked at $117K in Q4 2023. 69 funds tracked by Wall St. Rank hold ALXO as of Q1 2026.

  • Simplex Trading reported no remaining ALX Oncology position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 3,553 ALX Oncology shares in Q1 2026, an estimated $6.77K.
  • Simplex Trading first reported a position in ALX Oncology in Q1 2021 and held it in 10 quarters.
  • Simplex Trading's ALX Oncology position peaked at $117K in Q4 2023.
  • 69 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.